Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.11 - $0.83 $483 - $3,651
-4,399 Reduced 2.07%
207,755 $22,000
Q3 2022

Nov 14, 2022

BUY
$1.27 - $3.39 $250,217 - $667,904
197,022 Added 1302.02%
212,154 $225,000
Q2 2022

Oct 27, 2022

BUY
$1.44 - $3.94 $2,550 - $6,977
1,771 Added 13.25%
15,132 $28,000
Q2 2022

Aug 15, 2022

BUY
$1.44 - $3.94 $2,550 - $6,977
1,771 Added 13.25%
15,132 $28,000
Q1 2022

Oct 27, 2022

SELL
$2.86 - $8.83 $5,065 - $15,637
-1,771 Reduced 11.7%
13,361 $48,000
Q1 2022

May 13, 2022

BUY
$2.86 - $8.83 $2,296 - $7,090
803 Added 6.39%
13,361 $48,000
Q4 2021

Feb 14, 2022

SELL
$4.94 - $8.94 $6,990 - $12,650
-1,415 Reduced 10.13%
12,558 $109,000
Q3 2021

Nov 15, 2021

BUY
$6.05 - $10.81 $84,536 - $151,048
13,973 New
13,973 $105,000

Others Institutions Holding LHDX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Lucira Health, Inc.


  • Ticker LHDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,106,500
  • Market Cap $1.2M
  • Description
  • Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...
More about LHDX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.